34 Samples Reporting

Symptoms when uBiome was taken

Only symptoms associated with at least one abnormal metabolite are shown. This is based on Gut bacteria only.

Reset to All
Restricted to

Onset: less than 08 years since onset

---

Based on self-reporting

• General: Fatigue : 2
• Sleep: Unrefreshed sleep : 2
• General: Headaches : 2
• Autonomic Manifestations: nausea : 2
• Neuroendocrine Manifestations: worsening of symptoms with stress. : 2
• Neuroendocrine Manifestations: intolerance of extremes of heat and cold : 2
• Immune Manifestations: Bloating : 2
• Onset: less than 08 years since onset : 2
• Comorbid-Mouth: Bruxism - Jaw cleanching / Teeth grinding : 2
• Comorbid: Small intestinal bacterial overgrowth (SIBO) : 2
• Neuroendocrine Manifestations: Rapid muscular fatiguability : 2
• Neurological-Sleep: Inability for deep (delta) sleep : 2
• Comorbid-Mouth: Gingivits / Gum Disease : 1
• Gender: Female : 1
• Onset: 2010-2020 : 1
• Age: 20-30 : 1
• Age: 30-40 : 1
• Sleep: Daytime drowsiness : 1
• Pain: Sensitivity to pain : 1
• Neuroendocrine: Sweating hands : 1
• Neuroendocrine: Feeling like you have a high temperature : 1
• Autonomic: Nausea : 1
• Neurocognitive: Difficulty paying attention for a long period of time : 1
• Neurocognitive: Difficulty understanding things : 1
• Neurocognitive: Absent-mindedness or forgetfulness : 1
• Post-exertional malaise: Physically tired after minimum exercise : 1
• Post-exertional malaise: Muscle fatigue after mild physical activity : 1
• Immune Manifestations: vomiting : 1
• Autonomic: Vasovagal syncope (easy fainting) : 1
• Comorbid: Restless Leg : 1
• Asymptomatic: Minor Health Issues (a few symptoms only) : 1
• Asymptomatic: Live in house with person with probable microbiome dysfunction : 1
• Immune Manifestations: Alcohol Intolerant : 1
• Neuroendocrine Manifestations: Dry Eye (Sicca or Sjogren Syndrome) : 1
• Comorbid-Mouth: Dry Mouth : 1
• Immune Manifestations: Diarrhea : 1
• Neurological: Joint hypermobility : 1
• Neuroendocrine Manifestations: abnormal appetite : 1
• Immune Manifestations: tender lymph nodes : 1
• Immune Manifestations: recurrent flu-like symptoms : 1
• Immune Manifestations: general malaise : 1
• Neurological-Sleep: Insomnia : 1
• Neurological-Sleep: Prolonged Sleep : 1
• Autonomic Manifestations: irritable bowel syndrome : 1
• Autonomic Manifestations: urinary frequency dysfunction : 1
• Autonomic Manifestations: bladder dysfunction : 1
• Post-exertional malaise: Rapid muscular fatigability, : 1
• Post-exertional malaise: General : 1
• Neuroendocrine Manifestations: subnormal body temperature : 1
• Neuroendocrine Manifestations: cold extremities : 1
• Neurological: Impairment of concentration : 1
• Neurological-Vision: photophobia (Light Sensitivity) : 1
• Neurological-Audio: hypersensitivity to noise : 1
• Autonomic Manifestations: Postural orthostatic tachycardia syndrome (POTS) : 1
• Autonomic Manifestations: light-headedness : 1
• Neurological-Sleep: Chaotic diurnal sleep rhythms (Erratic Sleep) : 1
• Post-exertional malaise: Inappropriate loss of physical and mental stamina, : 1

Metabolites

Name	Low	High	Average	Count
Amino acid metabolism: D-Arginine and D-ornithine metabolism	2	0	0.5625	2
Amino acid metabolism: Tryptophan metabolism	1	0	0.9125	2
Bacterial Abilities: Phagosome	1	0	0.55	2
Carbohydrate metabolism: Ascorbate and aldarate metabolism	1	0	0.9125	2
Carbohydrate metabolism: Inositol phosphate metabolism	1	0	0.9125	2
Lipid metabolism: alpha-Linolenic acid metabolism	2	0	0.2	2
Lipid metabolism: Arachidonic acid metabolism	2	0	0.575	2
Lipid metabolism: Biosynthesis of unsaturated fatty acids	2	0	0.825	2
Lipid metabolism: Ether lipid metabolism	2	0	0.4375	2
Lipid metabolism: Steroid biosynthesis	1	0	0.55	2
Lipid metabolism: Steroid hormone biosynthesis	1	1	0.875	2
Secondary metabolite biosynthesis: Flavone and flavonol biosynthesis	1	1	1.6625	2
Secondary metabolite biosynthesis: Flavonoid biosynthesis	2	0	0.5625	2
Secondary metabolite biosynthesis: Stilbenoid, diarylheptanoid and gingerol biosynthesis	2	0	0.2	2
Secondary metabolite degradation: Atrazine degradation	2	0	0.825	2
Secondary metabolite degradation: Benzoate degradation	1	0	0.9125	2
Secondary metabolite degradation: Caprolactam degradation	2	0	0.575	2
Secondary metabolite degradation: Chloroalkane and chloroalkene degradation	1	0	0.9125	2
Secondary metabolite degradation: Chlorocyclohexane and chlorobenzene degradation	2	0	0.7	2
Secondary metabolite degradation: Dioxin degradation	1	0	0.7875	2
Secondary metabolite degradation: Drug metabolism - cytochrome P450	2	0	0.825	2
Secondary metabolite degradation: Ethylbenzene degradation	1	0	0.9125	2
Secondary metabolite degradation: Fluorobenzoate degradation	2	0	0.1	2
Secondary metabolite degradation: Metabolism of xenobiotics by cytochrome P450	2	0	0.825	2
Secondary metabolite degradation: Naphthalene degradation	1	0	0.9125	2
Secondary metabolite degradation: Styrene degradation	1	0	0.9125	2
Secondary metabolite degradation: Xylene degradation	1	0	0.7875	2
Vitamin metabolism: Ubiquinone and other terpenoid-quinone biosynthesis:	1	0	0.9125	2

Coming... foreach

---